Lenz Therapeutics, Inc. · NASDAQ:LENZ
BlackRock, Inc. reported a 5.10% stake in Lenz Therapeutics, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Oct 17, 2025
BlackRock, Inc. reported a 5.10% stake in Lenz Therapeutics, Inc., 1,442,864 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 1,442,864
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.10% | 1,442,864 |
Source
Related
- Lenz Therapeutics, Inc.
- BlackRock, Inc.
- Lenz Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 21, 2026
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Schedule 13G · Millennium Management LLC · Jun 26, 2026
- Schedule 13G · Squarepoint Ops LLC · Apr 8, 2026
- Schedule 13G/A · Ridgeback Capital Investments L.P. · Feb 17, 2026